Pharmacology Primer Techniques For More Effective and Strategic Drug Discovery 6Th Edition at Meripustak

Pharmacology Primer Techniques For More Effective and Strategic Drug Discovery 6Th Edition

Books from same Author: Terry Kenakin

Books from same Publisher: Elsevier

Related Category: Author List / Publisher List


  • Retail Price: ₹ 13530/- [ 11.00% off ]

    Seller Price: ₹ 12042

Sold By: T K Pandey      Click for Bulk Order

Offer 1: Get ₹ 111 extra discount on minimum ₹ 500 [Use Code: Bharat]

Offer 2: Get 11.00 % + Flat ₹ 100 discount on shopping of ₹ 1500 [Use Code: IND100]

Offer 3: Get 11.00 % + Flat ₹ 300 discount on shopping of ₹ 5000 [Use Code: MPSTK300]

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

Free Shipping Available



Click for International Orders
  • Provide Fastest Delivery

  • 100% Original Guaranteed
  • General Information  
    Author(s)Terry Kenakin
    PublisherElsevier
    ISBN9780323992893
    Pages502
    BindingPaperback
    LanguageEnglish
    Publish YearAugust 2022

    Description

    Elsevier Pharmacology Primer Techniques For More Effective and Strategic Drug Discovery 6Th Edition by Terry Kenakin

    A Pharmacology Primer: Techniques for More Effective and Strategic Drug Discovery, Sixth Edition features the latest research surrounding the application of pharmacology in drug discovery in an effort to equip readers with a deeper understanding of complex and rapid changes in this field. Written by well-respected pharmacologist, Terry P. Kenakin, this primer is an indispensable resource for anyone involved in drug discovery. This edition has been reorganized for better flow and clarity and includes material on new technologies for screening (virtual, DNA encoded libraires, fragment-based) and a major section on phenotypic (target agnostic) screening for new leads and determination of drug targets. With full color illustrations as well as new examples throughout, this book remains a top reference for all industry and academic scientists and students directly involved in drug discovery or pharmacologic research. New material includes a discussion of the determination of target engagement, including numerous new ways to demonstrate the physical interaction of molecules with drug targets and new drug candidates such a mRNA, gene therapy, antibodies and information on CRISPR and genomics.show more